8/15/2013 9:35:03 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
CORAL GABLES, Fla., Aug. 15, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, today announced financial results for the second quarter and six months period ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by